-
2
-
-
84862829106
-
Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood
-
Anglin D. Corcoran C. Brown A. Chen H. Lighty Q. Brook J. et al. (2012) Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. Schizophr Res 137: 45–49.
-
(2012)
Schizophr Res
, vol.137
, pp. 45-49
-
-
Anglin, D.1
Corcoran, C.2
Brown, A.3
Chen, H.4
Lighty, Q.5
Brook, J.6
-
3
-
-
0037164390
-
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
-
Arseneault L. Cannon M. Murray R. Poulton R. Caspi A. Moffitt T. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325: 1212–1213.
-
(2002)
BMJ
, vol.325
, pp. 1212-1213
-
-
Arseneault, L.1
Cannon, M.2
Murray, R.3
Poulton, R.4
Caspi, A.5
Moffitt, T.6
-
5
-
-
35348942818
-
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death
-
Athanasiou A. Clarke A. Turner A. Kumaran N. Vakilpour S. Smith P. et al. (2007) Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 364: 131–137.
-
(2007)
Biochem Biophys Res Commun
, vol.364
, pp. 131-137
-
-
Athanasiou, A.1
Clarke, A.2
Turner, A.3
Kumaran, N.4
Vakilpour, S.5
Smith, P.6
-
6
-
-
33745218113
-
Cannabis-induced psychosis-like experiences are associated with high schizotypy
-
Barkus E. Stirling J. Hopkins R. Lewis S. (2006) Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39: 175–178.
-
(2006)
Psychopathology
, vol.39
, pp. 175-178
-
-
Barkus, E.1
Stirling, J.2
Hopkins, R.3
Lewis, S.4
-
7
-
-
20844454912
-
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
-
Batkai S. Pacher P. Osei-Hyiaman D. Radaeva S. Liu J. Harvey-White J. et al. (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110: 1996–2002.
-
(2004)
Circulation
, vol.110
, pp. 1996-2002
-
-
Batkai, S.1
Pacher, P.2
Osei-Hyiaman, D.3
Radaeva, S.4
Liu, J.5
Harvey-White, J.6
-
8
-
-
0019604102
-
Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man
-
Benowitz N. Jones R. (1981) Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man. J Clin Pharmacol 21: 214S–223S.
-
(1981)
J Clin Pharmacol
, vol.21
, pp. 214S-223S
-
-
Benowitz, N.1
Jones, R.2
-
9
-
-
84870053882
-
Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function
-
31, January, (epub ahead of print)
-
Bhattacharyya S. Atakan Z. Martin-Santos R. Crippa J. Kambeitz J. Prata D. et al. (2012) Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry 31 January (epub ahead of print).
-
(2012)
Mol Psychiatry
-
-
Bhattacharyya, S.1
Atakan, Z.2
Martin-Santos, R.3
Crippa, J.4
Kambeitz, J.5
Prata, D.6
-
10
-
-
69249116618
-
Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology
-
Bhattacharyya S. Crippa J. Martin-Santos R. Winton-Brown T. Fusar-Poli P. (2009a) Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des 15: 2603–2614.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 2603-2614
-
-
Bhattacharyya, S.1
Crippa, J.2
Martin-Santos, R.3
Winton-Brown, T.4
Fusar-Poli, P.5
-
11
-
-
64849106877
-
Modulation of mediotemporal and ventrostriatal function in humans by delta-9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis
-
Bhattacharyya S. Fusar-Poli P. Borgwardt S. Martin-Santos R. Nosarti C. O’Carroll C. et al. (2009b) Modulation of mediotemporal and ventrostriatal function in humans by delta-9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66: 442–451.
-
(2009)
Arch Gen Psychiatry
, vol.66
, pp. 442-451
-
-
Bhattacharyya, S.1
Fusar-Poli, P.2
Borgwardt, S.3
Martin-Santos, R.4
Nosarti, C.5
O’Carroll, C.6
-
16
-
-
84860278770
-
Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis
-
Cascini F. Aiello C. Di Tanna G. (2011) Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev 5: 32-40.
-
(2011)
Curr Drug Abuse Rev
, vol.5
, pp. 32-40
-
-
Cascini, F.1
Aiello, C.2
Di Tanna, G.3
-
17
-
-
20944446077
-
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction
-
Caspi A. Moffitt T. Cannon M. McClay J. Murray R. Harrington H. et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117–1127.
-
(2005)
Biol Psychiatry
, vol.57
, pp. 1117-1127
-
-
Caspi, A.1
Moffitt, T.2
Cannon, M.3
McClay, J.4
Murray, R.5
Harrington, H.6
-
18
-
-
33846070616
-
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
-
Costa B. Trovato A. Comellii F. Giagnoni G. Colleoni M. (2007) The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol 556: 75–83.
-
(2007)
Eur J Pharmacol
, vol.556
, pp. 75-83
-
-
Costa, B.1
Trovato, A.2
Comellii, F.3
Giagnoni, G.4
Colleoni, M.5
-
19
-
-
78650625479
-
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: apreliminary report
-
Crippa J. Derenusson G. Ferrari T. Wichert-Ana L. Duran F. Martin-Santos R. et al. (2011) Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: apreliminary report. J Psychopharmacol 25: 121–130.
-
(2011)
J Psychopharmacol
, vol.25
, pp. 121-130
-
-
Crippa, J.1
Derenusson, G.2
Ferrari, T.3
Wichert-Ana, L.4
Duran, F.5
Martin-Santos, R.6
-
21
-
-
0036399623
-
Cognitive subjective dose–response effects of acute oral delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users
-
Curran H. Brignell C. Fletcher S. Middleton P. Henry J. (2002) Cognitive subjective dose–response effects of acute oral delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 164: 61–70.
-
(2002)
Psychopharmacology
, vol.164
, pp. 61-70
-
-
Curran, H.1
Brignell, C.2
Fletcher, S.3
Middleton, P.4
Henry, J.5
-
22
-
-
80051793829
-
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers
-
Dakwar E. Nunes E. Bisaga A. Carpenter K. Mariani J. Sullivan M. et al. (2011) A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict 20: 441–446.
-
(2011)
Am J Addict
, vol.20
, pp. 441-446
-
-
Dakwar, E.1
Nunes, E.2
Bisaga, A.3
Carpenter, K.4
Mariani, J.5
Sullivan, M.6
-
23
-
-
77950683424
-
Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia
-
Degenhardt L. Coffey C. Carlin J. Swift W. Moore E. Patton G. (2010) Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. Br J Psychiatry 196: 290–295.
-
(2010)
Br J Psychiatry
, vol.196
, pp. 290-295
-
-
Degenhardt, L.1
Coffey, C.2
Carlin, J.3
Swift, W.4
Moore, E.5
Patton, G.6
-
25
-
-
0024263922
-
Determination and characterization of a cannabinoid receptor in rat brain
-
Devane W. Dysarz F. Johnson M. Melvin L. Howlett A. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605–613.
-
(1988)
Mol Pharmacol
, vol.34
, pp. 605-613
-
-
Devane, W.1
Dysarz, F.2
Johnson, M.3
Melvin, L.4
Howlett, A.5
-
26
-
-
0027078685
-
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
-
Devane W. Hanus L. Breuer A. Pertwee R. Stevenson L. Griffin G. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949.
-
(1992)
Science
, vol.258
, pp. 1946-1949
-
-
Devane, W.1
Hanus, L.2
Breuer, A.3
Pertwee, R.4
Stevenson, L.5
Griffin, G.6
-
27
-
-
0022509199
-
Cannabinoid pharmacology
-
Dewey W. (1986) Cannabinoid pharmacology. Pharmacol Rev 38: 151–178.
-
(1986)
Pharmacol Rev
, vol.38
, pp. 151-178
-
-
Dewey, W.1
-
29
-
-
79953906205
-
Gut feelings about the endocannabinoid system
-
Di Marzo V. Piscitelli F. (2011) Gut feelings about the endocannabinoid system. Neurogastroenterol Motil 23: 391–398.
-
(2011)
Neurogastroenterol Motil
, vol.23
, pp. 391-398
-
-
Di Marzo, V.1
Piscitelli, F.2
-
30
-
-
79955632246
-
Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
-
Di Marzo V. Piscitelli F. Mechoulam R. (2011) Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol 203: 75–104.
-
(2011)
Handb Exp Pharmacol
, vol.203
, pp. 75-104
-
-
Di Marzo, V.1
Piscitelli, F.2
Mechoulam, R.3
-
31
-
-
3242789385
-
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
-
D’Souza D. Perry E. MacDougall L. Ammerman Y. Cooper T. Wu Y. et al. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558–1572.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 1558-1572
-
-
D’Souza, D.1
Perry, E.2
MacDougall, L.3
Ammerman, Y.4
Cooper, T.5
Wu, Y.6
-
34
-
-
84858287557
-
Are early-onset cannabis smokers at an increased risk of depression spells?
-
Fairman B. Anthony J. (2012) Are early-onset cannabis smokers at an increased risk of depression spells? J Affect Disord 138: 54–62.
-
(2012)
J Affect Disord
, vol.138
, pp. 54-62
-
-
Fairman, B.1
Anthony, J.2
-
35
-
-
58149096475
-
Looking for the role of cannabinoid receptor heteromers in striatal function
-
Ferré S. Goldberg S. Lluis C. Franco R. (2009) Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology 56(Suppl. 1): 226–234.
-
(2009)
Neuropharmacology
, vol.56
, pp. 226-234
-
-
Ferré, S.1
Goldberg, S.2
Lluis, C.3
Franco, R.4
-
37
-
-
33947489961
-
Isolation, structure and partial synthesis of an active constituent of hashish
-
Gaoni Y. Mechoulam R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646–1647.
-
(1964)
J Am Chem Soc
, vol.86
, pp. 1646-1647
-
-
Gaoni, Y.1
Mechoulam, R.2
-
38
-
-
33646837088
-
Methods for clinical research involving cannabis administration
-
Gorelick D. Heishman S. (2006) Methods for clinical research involving cannabis administration. Methods Mol Med 123: 235–253.
-
(2006)
Methods Mol Med
, vol.123
, pp. 235-253
-
-
Gorelick, D.1
Heishman, S.2
-
39
-
-
0344685410
-
Being stoned: a review of self-reported cannabis effects
-
Green B. Kavanagh D. Young R. (2003) Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22: 453–460.
-
(2003)
Drug Alcohol Rev
, vol.22
, pp. 453-460
-
-
Green, B.1
Kavanagh, D.2
Young, R.3
-
40
-
-
0031743712
-
Marijuana smoking vs cannabinoids for glaucoma therapy
-
Green K. (1998) Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol 116: 1433–1437.
-
(1998)
Arch Ophthalmol
, vol.116
, pp. 1433-1437
-
-
Green, K.1
-
41
-
-
34249999724
-
Prevalence and correlates of cannabis use in developed and developing countries
-
Hall W. Degenhardt L. (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20: 393–397.
-
(2007)
Curr Opin Psychiatry
, vol.20
, pp. 393-397
-
-
Hall, W.1
Degenhardt, L.2
-
42
-
-
37349071370
-
Cannabidiol potentiates pharmacological effects of delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism
-
Hayakawa K. Mishima K. Hazekawa M. Sano K. Orito K. et al. (2008) Cannabidiol potentiates pharmacological effects of delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism. Brain Res 1888: 157–164.
-
(2008)
Brain Res
, vol.1888
, pp. 157-164
-
-
Hayakawa, K.1
Mishima, K.2
Hazekawa, M.3
Sano, K.4
Orito, K.5
-
43
-
-
11244260452
-
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
-
Henquet C. Krabbendam L. Spauwen J. Kaplan C. Lieb R. Wittchen H. et al. (2004) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330: 11–14.
-
(2004)
BMJ
, vol.330
, pp. 11-14
-
-
Henquet, C.1
Krabbendam, L.2
Spauwen, J.3
Kaplan, C.4
Lieb, R.5
Wittchen, H.6
-
44
-
-
11244260452
-
Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people
-
Henquet C. Krabbendam L. Spauwen J. Kaplan C. Lieb R. Wittchen H. et al. (2005) Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people. BMJ 330: 11.
-
(2005)
BMJ
, vol.330
, pp. 11
-
-
Henquet, C.1
Krabbendam, L.2
Spauwen, J.3
Kaplan, C.4
Lieb, R.5
Wittchen, H.6
-
46
-
-
0035142746
-
In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor
-
Iwamura H. Suzuki H. Ueda Y. Kaya T. Inaba T. (2001) In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J Pharmacol Exp Ther 296: 420–425.
-
(2001)
J Pharmacol Exp Ther
, vol.296
, pp. 420-425
-
-
Iwamura, H.1
Suzuki, H.2
Ueda, Y.3
Kaya, T.4
Inaba, T.5
-
47
-
-
4444234226
-
Cannabinoids and intestinal motility: welcome to CB2 receptors
-
Izzo A. (2004) Cannabinoids and intestinal motility: welcome to CB2 receptors. Br J Pharmacol 142: 1201–1202.
-
(2004)
Br J Pharmacol
, vol.142
, pp. 1201-1202
-
-
Izzo, A.1
-
48
-
-
84998049299
-
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
-
9, December, (epub ahead of print)
-
Juknat A. Rimmerman N. Levy R. Vogel Z. Kozela E. (2011) Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. Neurochem Int 9 December (epub ahead of print).
-
(2011)
Neurochem Int
-
-
Juknat, A.1
Rimmerman, N.2
Levy, R.3
Vogel, Z.4
Kozela, E.5
-
49
-
-
0015537176
-
Comparative studies in man and in laboratory animals on 8- and 9-trans-tetrahydrocannabinol
-
Karniol I. Carlini E. (1973) Comparative studies in man and in laboratory animals on 8- and 9-trans-tetrahydrocannabinol. Pharmacology 9: 115–126.
-
(1973)
Pharmacology
, vol.9
, pp. 115-126
-
-
Karniol, I.1
Carlini, E.2
-
51
-
-
0032857273
-
Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta
-
Kenney S. Kekuda R. Prasad P. Leibach F. Devoe L. Ganapathy V. (1999) Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am J Obstet Gynecol 181: 491–497.
-
(1999)
Am J Obstet Gynecol
, vol.181
, pp. 491-497
-
-
Kenney, S.1
Kekuda, R.2
Prasad, P.3
Leibach, F.4
Devoe, L.5
Ganapathy, V.6
-
52
-
-
72549092256
-
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
-
Lakhan S. Rowland M. (2009) Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol 9: 59.
-
(2009)
BMC Neurol
, vol.9
, pp. 59
-
-
Lakhan, S.1
Rowland, M.2
-
53
-
-
0002649325
-
An archaeological and historical account of cannabis in China
-
Li H. (1973) An archaeological and historical account of cannabis in China. Economic Botany 28: 437–448.
-
(1973)
Economic Botany
, vol.28
, pp. 437-448
-
-
Li, H.1
-
54
-
-
33646814424
-
Cannabinoid receptors and endocannabinoids: evidence for new players
-
Mackie K. Stella N. (2006) Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 8: E298–E306.
-
(2006)
AAPS J
, vol.8
, pp. E298-E306
-
-
Mackie, K.1
Stella, N.2
-
55
-
-
40849137554
-
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
-
Marcellino D. Carriba P. Filip M. Borgkvist A. Frankowska M. Bellido I. et al. (2008) Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54: 815–823.
-
(2008)
Neuropharmacology
, vol.54
, pp. 815-823
-
-
Marcellino, D.1
Carriba, P.2
Filip, M.3
Borgkvist, A.4
Frankowska, M.5
Bellido, I.6
-
56
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
Matsuda L. Lolait S. Brownstein M. Young A. Bonner T. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564.
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Matsuda, L.1
Lolait, S.2
Brownstein, M.3
Young, A.4
Bonner, T.5
-
58
-
-
0029012014
-
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
-
Mechoulam R. Ben-Shabat S. Hanuš L. Ligumsky M. Kaminski N. Schatz A. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83–90.
-
(1995)
Biochem Pharmacol
, vol.50
, pp. 83-90
-
-
Mechoulam, R.1
Ben-Shabat, S.2
Hanuš, L.3
Ligumsky, M.4
Kaminski, N.5
Schatz, A.6
-
59
-
-
0033660254
-
A historical overview of chemical research on cannabinoids
-
Mechoulam R. Hanus L. (2000) A historical overview of chemical research on cannabinoids. Chems Phys Lipids 108: 1–13.
-
(2000)
Chems Phys Lipids
, vol.108
, pp. 1-13
-
-
Mechoulam, R.1
Hanus, L.2
-
60
-
-
0013768939
-
Hashish. I. The structure of cannabidiol
-
Mechoulam R. Shvo Y. (1963) Hashish. I. The structure of cannabidiol. Tetrahedron 19: 2073–2078.
-
(1963)
Tetrahedron
, vol.19
, pp. 2073-2078
-
-
Mechoulam, R.1
Shvo, Y.2
-
61
-
-
0037111841
-
Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signalling
-
Molina-Holgado E. Vela J. Arévalo-Martin A. Almazán G. Molina-Holgado F. Borrell J. et al. (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signalling. J Neurosci 22: 9742–9753.
-
(2002)
J Neurosci
, vol.22
, pp. 9742-9753
-
-
Molina-Holgado, E.1
Vela, J.2
Arévalo-Martin, A.3
Almazán, G.4
Molina-Holgado, F.5
Borrell, J.6
-
62
-
-
34447619511
-
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
-
Moore T. Zammit S. Lingford-Hughes A. Barnes T. Jones P. Burke M. et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319–328.
-
(2007)
Lancet
, vol.370
, pp. 319-328
-
-
Moore, T.1
Zammit, S.2
Lingford-Hughes, A.3
Barnes, T.4
Jones, P.5
Burke, M.6
-
63
-
-
17444393586
-
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
-
Moreira F. Guimaraes F. (2005) Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol 512: 199–205.
-
(2005)
Eur J Pharmacol
, vol.512
, pp. 199-205
-
-
Moreira, F.1
Guimaraes, F.2
-
64
-
-
84867326573
-
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
-
Morgan C. Gardener C. Schafer G. Swan S. Demarchi C. Freeman T. et al. (2011) Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol Med 29: 1–10.
-
(2011)
Psychol Med
, vol.29
, pp. 1-10
-
-
Morgan, C.1
Gardener, C.2
Schafer, G.3
Swan, S.4
Demarchi, C.5
Freeman, T.6
-
65
-
-
77957687873
-
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
-
Morgan C. Schafer G. Freeman T. Curran H. (2010) Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. Br J Psychiatry 197: 285–290.
-
(2010)
Br J Psychiatry
, vol.197
, pp. 285-290
-
-
Morgan, C.1
Schafer, G.2
Freeman, T.3
Curran, H.4
-
66
-
-
70449629796
-
The acute effects of synthetic intravenous delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
-
Morrison P. Zois V. McKeown D. Lee T. Holt D. Powell J. et al. (2009) The acute effects of synthetic intravenous delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med 39: 1607–1616.
-
(2009)
Psychol Med
, vol.39
, pp. 1607-1616
-
-
Morrison, P.1
Zois, V.2
McKeown, D.3
Lee, T.4
Holt, D.5
Powell, J.6
-
67
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
Munro S. Thomas K. Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61–65.
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.2
Abu-Shaar, M.3
-
68
-
-
55549147195
-
Detection of heteromers formed by cannabinoid CB2, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer
-
Navarro G. Carriba P. Gandia J. Ciruela F. Casadó V. Cortés A. et al. (2008) Detection of heteromers formed by cannabinoid CB2, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. ScientificWorldJournal 8: 1088–1097.
-
(2008)
ScientificWorldJournal
, vol.8
, pp. 1088-1097
-
-
Navarro, G.1
Carriba, P.2
Gandia, J.3
Ciruela, F.4
Casadó, V.5
Cortés, A.6
-
69
-
-
2442640362
-
Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults
-
Nicholson A. Turner C. Stone B. Robson P. (2004) Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24: 305–313.
-
(2004)
J Clin Psychopharmacol
, vol.24
, pp. 305-313
-
-
Nicholson, A.1
Turner, C.2
Stone, B.3
Robson, P.4
-
70
-
-
33751204139
-
Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up
-
Nunes E. Liu X. Samet S. Matseoane K. Hasin D. (2006) Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up. J Clin Psychiatry 67: 1561–1567.
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 1561-1567
-
-
Nunes, E.1
Liu, X.2
Samet, S.3
Matseoane, K.4
Hasin, D.5
-
71
-
-
32444440208
-
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
-
Pagotto U. Marsicano G. Cota D. Lutz B. Pasquali R. (2006) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73–100.
-
(2006)
Endocr Rev
, vol.27
, pp. 73-100
-
-
Pagotto, U.1
Marsicano, G.2
Cota, D.3
Lutz, B.4
Pasquali, R.5
-
72
-
-
84856456258
-
Psychopharmacology of the endocannabinoids: far beyond anandamide
-
Pamplona F. Takahashi R. (2012) Psychopharmacology of the endocannabinoids: far beyond anandamide. J Psychopharmacol 26: 7–22.
-
(2012)
J Psychopharmacol
, vol.26
, pp. 7-22
-
-
Pamplona, F.1
Takahashi, R.2
-
73
-
-
79960304851
-
Regulation of nausea and vomiting by cannabinoids
-
Parker L. Rock E. Limebeer C. (2011) Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 163: 1411–1422.
-
(2011)
Br J Pharmacol
, vol.163
, pp. 1411-1422
-
-
Parker, L.1
Rock, E.2
Limebeer, C.3
-
74
-
-
0030611978
-
Pharmacology of cannabinoid CB1 and CB2 receptors
-
Pertwee R. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129– 180.
-
(1997)
Pharmacol Ther
, vol.74
, pp. 129-180
-
-
Pertwee, R.1
-
75
-
-
33645502759
-
The pharmacology of cannabinoid receptors and their ligands: an overview
-
Pertwee R. (2006) The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes (Lond) 30: S13–S18.
-
(2006)
Int J Obes (Lond)
, vol.30
, pp. S13-S18
-
-
Pertwee, R.1
-
76
-
-
38349158960
-
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin
-
Pertwee R. (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153: 199–215.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 199-215
-
-
Pertwee, R.1
-
77
-
-
65449146377
-
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
-
Pertwee R. (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156: 397–411.
-
(2009)
Br J Pharmacol
, vol.156
, pp. 397-411
-
-
Pertwee, R.1
-
78
-
-
77950653576
-
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists
-
Pertwee R. (2010) Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 17: 1360–1381.
-
(2010)
Curr Med Chem
, vol.17
, pp. 1360-1381
-
-
Pertwee, R.1
-
79
-
-
78650120798
-
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2
-
Pertwee R. Howlett A. Abood M. Alexander S. Di Marzo V. Elphick M. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62: 588–631.
-
(2010)
Pharmacol Rev
, vol.62
, pp. 588-631
-
-
Pertwee, R.1
Howlett, A.2
Abood, M.3
Alexander, S.4
Di Marzo, V.5
Elphick, M.6
-
81
-
-
33144488036
-
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens
-
Pickel V. Chan J. Kearn C. Mackie K. (2006) Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 495: 299–313.
-
(2006)
J Comp Neurol
, vol.495
, pp. 299-313
-
-
Pickel, V.1
Chan, J.2
Kearn, C.3
Mackie, K.4
-
82
-
-
39049124647
-
Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology
-
Potter D. Clark P. Brown M. (2008) Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 53: 90–94.
-
(2008)
J Forensic Sci
, vol.53
, pp. 90-94
-
-
Potter, D.1
Clark, P.2
Brown, M.3
-
83
-
-
33744916587
-
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects
-
Raduner S. Majewska A. Chen J. Xie X. Hamon J. Faller B. et al. (2006) Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem 281: 14192–14206.
-
(2006)
J Biol Chem
, vol.281
, pp. 14192-14206
-
-
Raduner, S.1
Majewska, A.2
Chen, J.3
Xie, X.4
Hamon, J.5
Faller, B.6
-
84
-
-
84860895849
-
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
-
Ramer R. Bublitz K. Freimuth N. Merkord J. Rohde H. Haustein M. et al. (2012) Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J 26: 1535-1548.
-
(2012)
FASEB J
, vol.26
, pp. 1535-1548
-
-
Ramer, R.1
Bublitz, K.2
Freimuth, N.3
Merkord, J.4
Rohde, H.5
Haustein, M.6
-
85
-
-
0030756533
-
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase
-
Rhee M. Vogel Z. Barg J. Bayewitch M. Levy R. Hanus L. et al. (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40: 3228–3233.
-
(1997)
J Med Chem
, vol.40
, pp. 3228-3233
-
-
Rhee, M.1
Vogel, Z.2
Barg, J.3
Bayewitch, M.4
Levy, R.5
Hanus, L.6
-
87
-
-
28844489930
-
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol andcannabidiol
-
Russo E. Guy G. (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol andcannabidiol. Med Hypotheses 66: 234–246.
-
(2006)
Med Hypotheses
, vol.66
, pp. 234-246
-
-
Russo, E.1
Guy, G.2
-
88
-
-
34548483175
-
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine
-
Russo E. Guy G. Robson P. (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4: 1729–1743.
-
(2007)
Chem Biodivers
, vol.4
, pp. 1729-1743
-
-
Russo, E.1
Guy, G.2
Robson, P.3
-
89
-
-
0030425575
-
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands
-
Ther
-
Showalter V. Compton D. Martin B. Abood M. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278: 989–999.
-
(1996)
J Pharmacol Exp
, vol.278
, pp. 989-999
-
-
Showalter, V.1
Compton, D.2
Martin, B.3
Abood, M.4
-
91
-
-
51349095496
-
Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort
-
Stirling J. Barkus E. Nabosi L. Irshad S. Roemer G. Schreudergoidheijt B. et al. (2008) Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort. Psychopathology 41: 371–378.
-
(2008)
Psychopathology
, vol.41
, pp. 371-378
-
-
Stirling, J.1
Barkus, E.2
Nabosi, L.3
Irshad, S.4
Roemer, G.5
Schreudergoidheijt, B.6
-
92
-
-
84997908352
-
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
-
Stone J. (2011) Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia? Ther Adv Psychopharmacol 1: 5–18.
-
(2011)
Ther Adv Psychopharmacol
, vol.1
, pp. 5-18
-
-
Stone, J.1
-
94
-
-
68749088245
-
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
-
Terry G. Liow J. Zoghbi S. Hirvonen J. Farris A. Lerner A. (2009) Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage 48: 362–370.
-
(2009)
Neuroimage
, vol.48
, pp. 362-370
-
-
Terry, G.1
Liow, J.2
Zoghbi, S.3
Hirvonen, J.4
Farris, A.5
Lerner, A.6
-
95
-
-
0030561432
-
A community survey of adverse effects of cannabis use
-
Thomas H. (1996) A community survey of adverse effects of cannabis use, Drug Alcohol Depend 42: 201–207.
-
(1996)
Drug Alcohol Depend
, vol.42
, pp. 201-207
-
-
Thomas, H.1
-
97
-
-
0031929438
-
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
-
Tsou K. Brown S. Sanudo-Pena M. Mackie K. Walker J. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393–411.
-
(1998)
Neuroscience
, vol.83
, pp. 393-411
-
-
Tsou, K.1
Brown, S.2
Sanudo-Pena, M.3
Mackie, K.4
Walker, J.5
-
99
-
-
68949180394
-
Schizophrenia
-
van Os J. Kapur S. (2009) Schizophrenia. Lancet 374: 635–645.
-
(2009)
Lancet
, vol.374
, pp. 635-645
-
-
van Os, J.1
Kapur, S.2
-
100
-
-
84865982317
-
CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation
-
van Waes V. Beverley J. Siman H. Tseng K. Steiner H. (2012) CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation. Front Pharmacol 3: 21.
-
(2012)
Front Pharmacol
, vol.3
, pp. 21
-
-
van Waes, V.1
Beverley, J.2
Siman, H.3
Tseng, K.4
Steiner, H.5
-
101
-
-
79951472497
-
Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up
-
van Winkel R., Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2011) Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch Gen Psychiatry 68: 148–157.
-
(2011)
Arch Gen Psychiatry
, vol.68
, pp. 148-157
-
-
van Winkel, R.1
-
102
-
-
0035964576
-
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
-
Wallace M. Wiley J. Martin B. DeLorenzo R. (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428: 51–57.
-
(2001)
Eur J Pharmacol
, vol.428
, pp. 51-57
-
-
Wallace, M.1
Wiley, J.2
Martin, B.3
DeLorenzo, R.4
-
104
-
-
0003083642
-
Cannabinol, part I
-
Wood T. (1899) Cannabinol, part I. J Chem Soc 75: 20–36.
-
(1899)
J Chem Soc
, vol.75
, pp. 20-36
-
-
Wood, T.1
-
105
-
-
0037164374
-
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
-
Zammit S. Allebeck P. Andreasson S. Lundberg I. Lewis G. (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 325: 1199–1201.
-
(2002)
BMJ
, vol.325
, pp. 1199-1201
-
-
Zammit, S.1
Allebeck, P.2
Andreasson, S.3
Lundberg, I.4
Lewis, G.5
-
106
-
-
35948986314
-
Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use
-
Zammit S. Spurlock G. Williams H. Norton N. Williams N. O’Donovan M. et al. (2007) Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use Br J Psychiatry 191: 402–407.
-
(2007)
Br J Psychiatry
, vol.191
, pp. 402-407
-
-
Zammit, S.1
Spurlock, G.2
Williams, H.3
Norton, N.4
Williams, N.5
O’Donovan, M.6
-
107
-
-
0013549364
-
Cannabidiol as an anxiolytic and antipsychotic
-
In: Mathre M. (ed), Jefferson, NC: McFarland
-
Zuardi A. Guimaraes F. (1997) Cannabidiol as an anxiolytic and antipsychotic. In: Mathre M. (ed), Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana. Jefferson, NC: McFarland, p. 133–141.
-
(1997)
Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana
, pp. 133-141
-
-
Zuardi, A.1
Guimaraes, F.2
|